Study of COVID-19 immunity over time
Part of Infections, Lungs & breathing clinical trials.
This study looks at how people’s immune protection after COVID-19 may change over time. It aims to better understand immunity, which could help doctors plan future care and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older, or you must be under 18 with a legal guardian’s permission
- You must normally live in Hong Kong
- You must be able to communicate in spoken and written Chinese and/or English
- You should not have a mental illness
- You must not be a prisoner
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests community-based health education in Hong Kong to help people recognize COVID-19 early, get vaccinated, and use everyday self-protective steps. It may help participants learn practical ways to lower their risk and respond sooner if symptoms appear.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
This observational study follows how COVID-19 affects people in the UK over time. It may help researchers understand patterns of illness and health changes, without testing a new treatment.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.